MX2009006337A - Analogos de epotilona modificados en las posiciones c12-c13, como farmacos contra el cancer. - Google Patents

Analogos de epotilona modificados en las posiciones c12-c13, como farmacos contra el cancer.

Info

Publication number
MX2009006337A
MX2009006337A MX2009006337A MX2009006337A MX2009006337A MX 2009006337 A MX2009006337 A MX 2009006337A MX 2009006337 A MX2009006337 A MX 2009006337A MX 2009006337 A MX2009006337 A MX 2009006337A MX 2009006337 A MX2009006337 A MX 2009006337A
Authority
MX
Mexico
Prior art keywords
positions
anticancer drugs
analogues modified
epothilone analogues
epothilone
Prior art date
Application number
MX2009006337A
Other languages
English (en)
Inventor
Kari-Heinz Altmann
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2009006337A publication Critical patent/MX2009006337A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

La invención se refiere a análogos de epotilonas de las fórmulas (A), (B), (I), y (II): (ver fórmulas (A), (B), (I) y (II)) a los usos y métodos para la elaboración de los mismos.
MX2009006337A 2006-12-14 2007-12-12 Analogos de epotilona modificados en las posiciones c12-c13, como farmacos contra el cancer. MX2009006337A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06126141 2006-12-14
PCT/EP2007/010846 WO2008071404A1 (en) 2006-12-14 2007-12-12 Epothilone analogues modified at positions c12-c13 as anticancer drugs

Publications (1)

Publication Number Publication Date
MX2009006337A true MX2009006337A (es) 2009-06-23

Family

ID=37930375

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009006337A MX2009006337A (es) 2006-12-14 2007-12-12 Analogos de epotilona modificados en las posiciones c12-c13, como farmacos contra el cancer.

Country Status (11)

Country Link
US (1) US20100022596A1 (es)
EP (1) EP2094713A1 (es)
JP (1) JP2010512359A (es)
KR (1) KR20090082486A (es)
CN (1) CN101558074A (es)
AU (1) AU2007331722A1 (es)
BR (1) BRPI0720309A2 (es)
CA (1) CA2671336A1 (es)
EA (1) EA200900780A1 (es)
MX (1) MX2009006337A (es)
WO (1) WO2008071404A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102276597B (zh) * 2010-01-12 2013-10-16 山东大学 14元大环内酯类埃博霉素化合物及其应用
CN105797168A (zh) 2010-05-18 2016-07-27 天蓝制药公司 用于治疗自身免疫性疾病或其它疾病的组合物和方法
CN101973987B (zh) * 2010-10-18 2012-08-22 天津尚德药缘科技有限公司 埃博霉素类似物，制备方法及其药物组合物和用途
JP5950691B2 (ja) * 2012-02-09 2016-07-13 シャープ株式会社 情報処理システム、情報処理装置、及び通信接続方法
US9102624B2 (en) 2012-08-23 2015-08-11 Boehringer Ingelheim International Gmbh Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity
JP6314951B2 (ja) * 2015-10-08 2018-04-25 コニカミノルタ株式会社 画像形成システムおよびプログラム
CN112479993A (zh) * 2019-09-11 2021-03-12 凯瑞斯德生化(苏州)有限公司 一种应用于kras抑制剂类药物杂环中间体的合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1392664A4 (en) * 2001-06-01 2005-01-26 Bristol Myers Squibb Co EPOTHILONE DERIVATIVES

Also Published As

Publication number Publication date
CA2671336A1 (en) 2008-06-19
CN101558074A (zh) 2009-10-14
EA200900780A1 (ru) 2010-08-30
BRPI0720309A2 (pt) 2013-12-24
JP2010512359A (ja) 2010-04-22
AU2007331722A1 (en) 2008-06-19
KR20090082486A (ko) 2009-07-30
US20100022596A1 (en) 2010-01-28
WO2008071404A1 (en) 2008-06-19
EP2094713A1 (en) 2009-09-02

Similar Documents

Publication Publication Date Title
WO2007093627A3 (de) Biozide zusammensetzung
WO2008083248A3 (en) Cyclopamine analogs
MX2009004766A (es) Derivados de espiroindolinona.
WO2007015017A3 (fr) Nouveaux derives de polyquinoleines et leur utilisation therapeutique
WO2009077443A3 (de) Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
MX2009006337A (es) Analogos de epotilona modificados en las posiciones c12-c13, como farmacos contra el cancer.
MX2009012345A (es) Derivados de 3,3-espiroindolinona.
WO2009077500A3 (de) Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
WO2008070268A3 (en) Pharmaceutical compositions
WO2008017079A3 (en) Dyes and precursors and conjugates thereof
AU2008303600A8 (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
UA97369C2 (ru) Противоопухолевые соединения дигидропиран-2-она и фармацевтическая композиция на их основе
WO2008153154A1 (ja) 環状化合物、フォトレジスト基材及びフォトレジスト組成物
MX2009013354A (es) Compuestos de triarilo y composiciones que los contienen.
TW200732410A (en) Sprayable acoustic compositions
MY146671A (en) Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
WO2008073863A3 (en) Preparation and utility of substituted allylamines
MX2009008249A (es) Composicion farmaceutica que comprende derivado de camptotecina.
WO2008019030A3 (en) Modified azole compounds as antiinfective agents
UA96476C2 (ru) Фармацевтические композиции, которые содержат ирбесартан
WO2008056360A3 (en) Chickpea composition
TW200635586A (en) Composition comprising an epothilone and methods for producing a composition comprising an epothilone
DE602007006962D1 (en) Thienoä3,2-cüpyridin-7-carbonsäure-derivate
HK1131156A1 (en) Novel morphine derivatives
DE602007010779D1 (en) Neue 4-amino-3-(-azolylphenoxymethyl)thienoä3,2-cüpyridin-7-carbonsäurederivate

Legal Events

Date Code Title Description
HH Correction or change in general
FA Abandonment or withdrawal